Itraconazole.
Ketoconazole, except preparations and mixtures containing not more than 1,0 percent of ketaconazole,
when intended for the prevention and treatment of dandruff and except when intended for application to
the skin. (S0, S1)
Ketorolac trometamol, except when intended for ophthalmic use. (S3)
Lamivudine.
Lansoprazole, except when intended for the temporary short-term relief of heartburn and hyperacidity,
subject to—
(a)
a maximum daily dose of 15mg
(b)
a maximum treatment period of 14 days. (S2).
Latanoprost.
Leflunomide.
Letrozole.
Levallorphan.
Levamisole, except when intended and registered as an anthelmintic and an immunomodulator in terms
of the provisions of the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act, 1947.
Levobupivacaine.
Liarozole.
Local anaesthetics, when intended for ophthalmic and parenteral use, except oxybuprocaine,
proxymetacaine and tetracaine, when contained in eye drops intended for emergency treatment of arc
eyes, and except lignocaine when contained in antimicrobial preparations for injection as well as in
ophthalmic preparations registered in terms of the provisions of the Fertilizers, Farm Feeds, Agricultural
Remedies and Stock Remedies Act, 1947.
Lomustine.
Lopinavir.
Lovastatin.
Lumefantrine.
Lysozyme, except preparations and mixtures when intended for application to the skin. (S1)
Mecamylamine.
Mefloquine.
Melarsoprol, when intended for injection.
Melphalan and its derivatives, unless listed in another Schedule.
Mephentermine.
Mepirizole.
2-mercaptopropionyl glycine.
6-mercaptopurine and its derivatives, unless listed in another Schedule.
Mercury; preparations and mixtures that contain mercury metal and that are intended for medicinal use.
Mesna, where intended for injection. (S2)
Metaproterenol (orciprenaline), where intended for the prevention or delay of labour, and preparations
thereof for injection. (S2, S3)
Metergoline.
Methacholine.
Methampyrone.
Methotrexate.
Methoxsalen.
Methysergide.
Metoclopramide.
Metomidate.
Metronidazole.
Mexiletine.
Miconazole, except where intended for application to the skin and except where intended for human
vaginal use, specifically for the treatment of recurrent vaginal candidiasis (S1), and except where
intended for human use in preparations containing 2 per cent or less of miconazole, where intended for
the topical treatment of fungal infections of the mouth (oral candidiasis) (S2).
Mifepristone.
Miglitol.
Milrinone.
Miltefosine.
Minoxidil, except when intended for application to the scalp. (S2)
Misoprostol.
Mitomycin C.
Mitoxantrone.
Mivacurium.
Mizolastine.
Mofebutazone.
Malgramostim.
Mometasone.